Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCR100 Injection in Knee Osteoarthritis (Phase Ib/II, Multicenter, China)
CTR20252010Phase 2Active
- Sponsor
- Zhongsheng Suyuan
- Start
- Jun 2025
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of NCR100 in knee osteoarthritis (OA), sponsored by Zhongsheng Suyuan. Started Jun 2025; status: active.
02
Drugs
NCR100
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on CTR20252010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252010.